625
Participants
Start Date
March 31, 2013
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Hydrocodone ER
"During the open-label, titration period, all participants were administered hydrocodone ER tablets at dosages of 15, 30, 45, 60, or 90 mg every 12 hours to identify a dosage deemed successful for managing their pain.~Hydrocodone ER was taken by participants randomized to the hydrocodone ER treatment arm during the double-blind treatment period at the dose level identified during the titration period.~Participants were instructed to take tablets with a glass of water on an empty stomach at least 1 hour before or 2 hours after eating."
Placebo
"Placebo matching the active drug dose identified during the titration period was taken by participants randomized to the placebo treatment arm during the double-blind treatment period.~Participants were instructed to take intervention with a glass of water on an empty stomach at least 1 hour before or 2 hours after eating."
Teva Investigational Site 10416, Anniston
Teva Investigational Site 10382, Birmingham
Teva Investigational Site 10403, Birmingham
Teva Investigational Site 10412, Birmingham
Teva Investigational Site 10426, Mobile
Teva Investigational Site 10436, Montgomery
Teva Investigational Site 10363, Phoenix
Teva Investigational Site 10366, Phoenix
Teva Investigational Site 10437, Tucson
Teva Investigational Site 10358, Anaheim
Teva Investigational Site 10408, Bell Gardens
Teva Investigational Site 10425, Carmichael
Teva Investigational Site 10390, Cerritos
Teva Investigational Site 10429, El Cajon
Teva Investigational Site 10423, Escondido
Teva Investigational Site 10740, Garden Grove
Teva Investigational Site 10391, Huntington Park
Teva Investigational Site 10422, La Jolla
Teva Investigational Site 10413, Laguna Hills
Teva Investigational Site 10442, Laguna Hills
Teva Investigational Site 10370, Los Angeles
Teva Investigational Site 10392, Sherman Oaks
Teva Investigational Site 10398, Thousand Oaks
Teva Investigational Site 10428, Torrance
Teva Investigational Site 10361, Walnut Creek
Teva Investigational Site 10441, Waterbury
Teva Investigational Site 10369, DeLand
Teva Investigational Site 10744, Edgewater
Teva Investigational Site 10379, Fort Lauderdale
Teva Investigational Site 10365, Jacksonville
Teva Investigational Site 10445, Leesburg
Teva Investigational Site 10362, Orlando
Teva Investigational Site 10381, Ormond Beach
Teva Investigational Site 12036, Pembroke Pines
Teva Investigational Site 10357, Plantation
Teva Investigational Site 10367, Royal Palm Beach
Teva Investigational Site 10435, Royal Palm Beach
Teva Investigational Site 10742, Sanford
Teva Investigational Site 10432, Columbus
Teva Investigational Site 10383, Marietta
Teva Investigational Site 10385, Marietta
Teva Investigational Site 10444, Newnan
Teva Investigational Site 10431, Meridian
Teva Investigational Site 10743, Meridian
Teva Investigational Site 10411, Chicago
Teva Investigational Site 10418, Avon
Teva Investigational Site 10380, Evansville
Teva Investigational Site 10440, Newburgh
Teva Investigational Site 10375, Overland Park
Teva Investigational Site 10419, New Orleans
Teva Investigational Site 10359, Shreveport
Teva Investigational Site 10389, Fall River
Teva Investigational Site 10388, Bay City
Teva Investigational Site 10397, Biloxi
Teva Investigational Site 10406, Hazelwood
Teva Investigational Site 10401, St Louis
Teva Investigational Site 10376, Omaha
Teva Investigational Site 10396, Omaha
Teva Investigational Site 10417, Henderson
Teva Investigational Site 10399, Las Vegas
Teva Investigational Site 10409, Berlin
Teva Investigational Site 10439, Buffalo
Teva Investigational Site 10394, New York
Teva Investigational Site 10407, New York
Teva Investigational Site 10410, New York
Teva Investigational Site 10443, Raleigh
Teva Investigational Site 10414, Winston-Salem
Teva Investigational Site 10446, Oklahoma City
Teva Investigational Site 10415, Altoona
Teva Investigational Site 10430, Duncansville
Teva Investigational Site 10386, Mechanicsburg
Teva Investigational Site 10373, Tipton
Teva Investigational Site 10404, North Charleston
Teva Investigational Site 10741, Spartanburg
Teva Investigational Site 10405, Austin
Teva Investigational Site 10364, Dallas
Teva Investigational Site 10372, Dallas
Teva Investigational Site 10395, Dallas
Teva Investigational Site 10371, Houston
Teva Investigational Site 12035, Houston
Teva Investigational Site 10377, Lake Jackson
Teva Investigational Site 10374, Plano
Teva Investigational Site 10378, San Antonio
Teva Investigational Site 10402, Salt Lake City
Teva Investigational Site 10438, Roanoke
Teva Investigational Site 10420, Bellevue
Teva Investigational Site 10433, Everett
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY